Pneumocandin B0
Alternative Names: L 688786Latest Information Update: 12 Feb 2008
At a glance
- Originator Merck & Co
- Class Antifungals; Echinocandins
- Mechanism of Action Glucan synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Mycoses; Pneumocystis pneumonia
Most Recent Events
- 04 Oct 1995 No Development Reported for Mycoses in USA (unspecified route)